Endomedical Center OOD
- Address
- 14-20 Sveti Georgi Sofiyski Str., 1431 Sofia, Bulgaria
Endomedical Center OOD - Lipid Disorders Research
Endomedical Center OOD is a clinical research facility specializing in metabolic and endocrine disorders, with particular expertise in lipid metabolism abnormalities. The center conducts advanced Phase 3 clinical trials evaluating innovative therapeutic interventions for patients with complex metabolic conditions.
- Severe hypertriglyceridemia treatment and management
- Novel pharmacological agents for lipid disorders
- Long-term efficacy and safety assessment of metabolic therapies
The center's research portfolio includes evaluation of pegozafermin, a promising therapeutic agent targeting fasting serum triglyceride levels in patients with severe hypertriglyceridemia. Through rigorous 26-week treatment protocols, Endomedical Center OOD contributes to advancing the understanding and management of lipid metabolism disorders, ultimately improving outcomes for patients at risk of cardiovascular complications associated with elevated triglyceride levels.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Kailera Therapeutics Inc.2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Kailera Therapeutics Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Endomedical Center OOD
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Study to Compare the Efficacy and Safety of KAI-9531 Versus Semaglutide in Participants Living with Obesity Without Diabetes | Kailera Therapeutics Inc. | Phase III | Recruiting | Jun 2026 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| HRS 9531 | 2 | Unknown | 2026-06-24 | 2026-06-25 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.